Interestingly, we found that circNF1 was tightly related to the therapeutic efficacy of anti-PD-L1 immunotherapy according to the microarray results, which prompted us to explore the biological function of circNF1 in ESCC. This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.